With Wisecube Discover, more effectively prioritize and select the right compounds used in developing your next test pipeline. Using deep neural networks and other advanced AI techniques, optimize your drug development pipeline from target selection and validation, all the way to clinical trials.
Filtering out the wrong compounds, sorting, and ranking the right compounds becomes more important than ever. Using Wisecube, enable a more focused approach on what molecules you spend your time evaluating and purchasing.
Given the high depreciation rates, high costs and slow approval processes of new drug discoveries, repurposing of previously approved drugs to treat diseases are becoming more attractive with the use of existing approved compounds, potentially lowering development costs and increasing revenue opportunities.
Using the latest machine learning and AI techniques, Wisecube provides solutions that can predict patient readmission for specified diseases with associated risk scoring within defined time periods.
There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour, or randomised words which don't look even slightly believable.